TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Profit Margins
Over the twelve months to 2026-06-30, TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) had gross margin 52.5%, operating margin 9.3%, net margin 4.1%, free cash flow margin 7.8%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TEVATEVA PHARMACEUTICAL INDUSTRIES LTDFollow TEVA — free
—
Price chart with a free account
- Market cap
- 45.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 45.7% | 56.2% | 52.0% | 52.4% | 52.7% | 45.4% | 44.6% | 46.4% | 47.8% | 46.7% | 48.2% | 48.7% | 51.8% | 52.5% | |
| Operating margin | 14.9% | 24.0% | 17.0% | 10.9% | 8.1% | -9.0% | -2.6% | -21.4% | 10.8% | -14.7% | 2.7% | -1.8% | 12.5% | 9.3% | |
| Net margin | 12.4% | 20.7% | 15.1% | 9.7% | 6.2% | -11.8% | -5.9% | -24.0% | 2.6% | -16.4% | -3.5% | -9.9% | 8.2% | 4.1% | |
| FCF margin | 16.5% | 21.3% | 16.8% | 17.1% | 10.9% | 9.8% | 1.3% | 3.8% | 1.5% | 7.0% | 5.3% | 4.5% | 6.7% | 7.8% |
USD billions · SEC XBRL
TEVA PHARMACEUTICAL INDUSTRIES LTD — questions
- What is TEVA PHARMACEUTICAL INDUSTRIES LTD's gross margin?
- 52.5% over the twelve months to 2026-06-30.
- What is TEVA PHARMACEUTICAL INDUSTRIES LTD's operating margin?
- 9.3% over the twelve months to 2026-06-30.
- What is TEVA PHARMACEUTICAL INDUSTRIES LTD's net profit margin?
- 4.1% over the twelve months to 2026-06-30.
Every figure on this page comes from TEVA PHARMACEUTICAL INDUSTRIES LTD's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.